HER2/positive and HER2/low in inflammatory breast cancer recurrence

This study aimed to investigate the impact of HER2-low on the risk of recurrence in individuals with inflammatory breast cancer (IBC). 60 females with HER2-low and HER2-positive IBC underwent surgery between July 2020 and July 2022. Patients were divided into three groups of 20 patients: (1) HRplus/...

Descripción completa

Detalles Bibliográficos
Autores principales: Movchan, Oleksii Volodimirovich, Bagmut, Irina Yuriivna, Shipko, Andriy Fedorovich, Smolanka (Senior), Ivan Ivanovich, Sheremet, Michael Ivanovich, Kolisnyk, Igor Leonidovich, Bagmut, Oleksandr Vasyliovych, Lyashenko, Andriy Oleksandrovich, Loboda, Anton Dmitrovich, Ivankova, Oksana Mykolaivna, Dosenko, Irina Viktorivna, Lazaruk, Oleksandr Volodimirovich, Gyrla, Yan Viktorovich, Bilookyi, Oleksandr Vyacheslavovich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884346/
https://www.ncbi.nlm.nih.gov/pubmed/36762329
http://dx.doi.org/10.25122/jml-2022-0213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884346/
https://www.ncbi.nlm.nih.gov/pubmed/36762329
http://dx.doi.org/10.25122/jml-2022-0213

Ejemplares similares